185 related articles for article (PubMed ID: 15598770)
1. The economic impact of false-positive cancer screens.
Lafata JE; Simpkins J; Lamerato L; Poisson L; Divine G; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2126-32. PubMed ID: 15598770
[TBL] [Abstract][Full Text] [Related]
2. Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Andriole GL; Kramer BS; Hayes RB; Prorok PC; Gohagan JK;
J Urol; 2005 Mar; 173(3):746-50; discussion 750-1. PubMed ID: 15711261
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
6. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
7. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
[TBL] [Abstract][Full Text] [Related]
9. Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence.
Ford ME; Havstad SL; Flickinger L; Johnson CC
Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):28-33. PubMed ID: 12540500
[TBL] [Abstract][Full Text] [Related]
10. Understanding the financial impact of covering new screening technologies. The case of automated Pap smears.
McQuarrie HG; Ogden J; Costa M
J Reprod Med; 2000 Nov; 45(11):898-906. PubMed ID: 11127101
[TBL] [Abstract][Full Text] [Related]
11. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
12. The impact of including future medical care costs when estimating the costs attributable to a disease: a colorectal cancer case study.
Etzioni R; Ramsey SD; Berry K; Brown M
Health Econ; 2001 Apr; 10(3):245-56. PubMed ID: 11288190
[TBL] [Abstract][Full Text] [Related]
13. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.
Andriole GL; Reding D; Hayes RB; Prorok PC; Gohagan JK;
Urol Oncol; 2004; 22(4):358-61. PubMed ID: 15283897
[TBL] [Abstract][Full Text] [Related]
14. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
[TBL] [Abstract][Full Text] [Related]
15. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
Krahn MD; Coombs A; Levy IG
CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
[TBL] [Abstract][Full Text] [Related]
16. Cost of care for elderly cancer patients in the United States.
Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
[TBL] [Abstract][Full Text] [Related]
17. Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.
Pinsky PF; Crawford ED; Kramer BS; Andriole GL; Gelmann EP; Grubb R; Greenlee R; Gohagan JK
BJU Int; 2007 Apr; 99(4):775-9. PubMed ID: 17223921
[TBL] [Abstract][Full Text] [Related]
18. Experiences of patients with false positive results from colorectal cancer screening.
Mant D; Fitzpatrick R; Hogg A; Fuller A; Farmer A; Verne J; Northover J
Br J Gen Pract; 1990 Oct; 40(339):423-5. PubMed ID: 2271264
[TBL] [Abstract][Full Text] [Related]
19. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
Ladabaum U; Song K
Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069
[TBL] [Abstract][Full Text] [Related]
20. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]